Putnam Investments’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$387K Buy
10,648
+732
+7% +$25.1K ﹤0.01% 1016
2023
Q3
$364K Sell
9,916
-80
-0.8% -$3.19K ﹤0.01% 1005
2023
Q2
$383K Buy
+9,996
New +$369K ﹤0.01% 1007
2017
Q1
Sell
-131,776
Closed -$7.72M 1240
2016
Q4
$7.72M Buy
+131,776
New +$6.96M 0.02% 443

Other funds holding ADNT

Putnam Investments's ADNT Position: Q4 2023 in Review

Putnam Investments increased its Adient (ADNT) stake by 7.4% in Q4 2023, buying an estimated $25.1K and bringing the position to 10,648 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Putnam Investments first reported a position in ADNT in Q4 2016 and has held it in 4 quarters since. The position peaked at $7.72M in Q4 2016. 303 funds tracked by Wall St. Rank hold ADNT as of Q4 2023.

  • Putnam Investments held 10,648 shares of Adient worth $387K as of Q4 2023.
  • Putnam Investments bought 732 Adient shares in Q4 2023, an estimated $25.1K.
  • Adient made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1016 holding.
  • Putnam Investments first reported a position in Adient in Q4 2016 and has held it in 4 quarters since.
  • Putnam Investments's Adient position peaked at $7.72M in Q4 2016.
  • 303 funds tracked by Wall St. Rank held Adient as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.